We’re excited to announce that Radhakrishnan Venkatasamy , our Principal Research Scientist specializing in autoimmune diseases, will be attending From Innovation to Adoption in Gene Therapies, hosted by One Nucleus on Thursday, 27 February 2025 at Level 39, Canary Wharf, London. This event brings together experts to explore the latest advancements in gene therapies, and Radhakrishnan is eager to connect with fellow innovators to discuss new opportunities for collaboration. Let’s work together to accelerate drug discovery and development! 📍 Event details: 📅 Date: Thursday, 27 February 2025 ⏰ Time: 15:00 – 19:30 📍 Location: Level 39, One Canada Square, Canary Wharf, London E14 5AB 🔗 More info: (https://lnkd.in/efEUWfCJ) 💬 Interested in partnering with Pharmidex? Connect with Radhakrishnan at the event or reach out to us!

Pharmidex continues to drive innovation in computational drug discovery! Following Molecular Docking, our Pharmacophore Modeling step refines drug design by identifying key molecular features essential for target binding, enhancing lead optimization. ✨ Why is this step crucial? ✅ Defines essential chemical and spatial features for drug activity ✅ AI-driven modeling for precise hit identification ✅ Optimizes drug-target interactions for enhanced efficacy ✅ Seamlessly integrates with our in silico pipeline for accelerated discovery With advanced computational tools and scientific expertise, we de-risk drug development and accelerate therapeutic breakthroughs. 📽️ Watch our latest video (4/5) to see how Pharmacophore Modeling refines drug design! 📩 Let’s collaborate to advance drug discovery! #DrugDiscovery #Pharmidex #AIinBiotech #PharmacophoreModeling #PharmaceuticalInnovation

Pharmidex continues advancing computational drug discovery! After identifying active/binding sites, our Molecular Docking step ensures precise interaction analysis between potential drug candidates and target proteins, streamlining lead optimization. ✨ Why is this step key? ✅ Predicts binding affinity and stability of drug candidates ✅ AI-enhanced docking for high-precision molecular interactions ✅ Accelerates hit-to-lead identification with accurate simulations ✅ Seamlessly integrates with the next in silico pipeline steps By combining cutting-edge modeling and expert-driven analysis, we de-risk drug development and fast-track novel therapeutic discoveries. 📽️ Watch our latest video (3/5) showcasing how we refine drug-target interactions through Molecular Docking! 📩 Let’s collaborate to transform drug discovery! #DrugDiscovery #Pharmidex #AIinBiotech #MolecularDocking #PharmaceuticalInnovation

OBN BioTuesday

At Pharmidex , we continue to push the boundaries of computational drug discovery! Following target structure and ligand determination, our advanced Determination of Active/Binding Sites step ensures precise identification of key molecular interactions, optimizing drug design for success. ✨ Why is this step crucial? ✅ Accurate identification of binding pockets for targeted drug interactions ✅ AI-powered pocket detection and molecular dynamics simulations ✅ Enhanced precision in hit identification and lead optimization ✅ Seamless integration with our next in silico pipeline steps By leveraging cutting-edge computational tools, we de-risk drug development and accelerate therapeutic innovation. Stay tuned for the next stage in our in silico pipeline! 📽️ Watch our latest video (2/5) to explore how we map active sites with precision! 📩 Let’s collaborate to revolutionize drug discovery! #DrugDiscovery #Pharmidex #AIinBiotech #MolecularModeling #PharmaceuticalInnovation